Pilot study: immune checkpoints polymorphisms in greek primary breast cancer patients

HIGHLIGHTS

• who: Nyanbol Kuol and collaborators from the Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia have published the research: Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients, in the Journal: Biomedicines 2022, 1827 PEER REVIEW Biomedicines 2022, 10,10, x FOR of /2022/
• what: This study evaluated functional single nucleotide polymorphisms of PD-1 PD-L1 and PD-L2 with primary breast cancer subtypes luminal A and luminal B.
• how: Similarly the protein expression data showed that PD-L1 and PD-L2 are associated with an aggressive phenotype . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.